Dai, D., Mao, Y., Jin, H., & Zhang, W. (2019). Efficacy and hypoglycemic risk of sitagliptin in obese/overweight patients with type 2 diabetes compared with GLP-1 receptor agonists: A meta-analysis. Medicine (Baltimore).
Citação norma ChicagoDai, Danping, Yiyang Mao, Haiying Jin, and Wei Zhang. "Efficacy and Hypoglycemic Risk of Sitagliptin in Obese/overweight Patients With Type 2 Diabetes Compared With GLP-1 Receptor Agonists: A Meta-analysis." Medicine (Baltimore) 2019.
Citação norma MLADai, Danping, Yiyang Mao, Haiying Jin, and Wei Zhang. "Efficacy and Hypoglycemic Risk of Sitagliptin in Obese/overweight Patients With Type 2 Diabetes Compared With GLP-1 Receptor Agonists: A Meta-analysis." Medicine (Baltimore) 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.